Louis Moore Bacon's GMAB Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 211,705 shares of Genmab A/S (GMAB) worth $5.68 M, representing 0.12% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Louis Moore Bacon has initiated a new position in GMAB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Genmab A/S (GMAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genmab A/S (GMAB) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +211,705 | New Buy | 211,705 | $26.83 |
Louis Moore Bacon's Genmab A/S Investment FAQs
Louis Moore Bacon first purchased Genmab A/S (GMAB) in Q1 2026, acquiring 211,705 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Genmab A/S (GMAB) for 1 quarters since Q1 2026.
Louis Moore Bacon's largest addition to Genmab A/S (GMAB) was in Q1 2026, adding 211,705 shares worth $5.68 M.
According to the latest 13F filing for Q1 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 211,705 shares of Genmab A/S (GMAB), valued at approximately $5.68 M.
As of the Q1 2026 filing, Genmab A/S (GMAB) represents approximately 0.12% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Genmab A/S (GMAB) was 211,705 shares, as reported at the end of Q1 2026.